Wellington Management Group LLP Buys 445,796 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Wellington Management Group LLP grew its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,276,237 shares of the company's stock after acquiring an additional 445,796 shares during the quarter. Wellington Management Group LLP owned about 1.37% of LifeStance Health Group worth $38,886,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. SG Americas Securities LLC raised its holdings in shares of LifeStance Health Group by 65.7% during the 4th quarter. SG Americas Securities LLC now owns 90,355 shares of the company's stock valued at $666,000 after buying an additional 35,823 shares in the last quarter. Blue Trust Inc. grew its position in shares of LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after buying an additional 2,122 shares during the last quarter. R Squared Ltd bought a new stake in shares of LifeStance Health Group in the 4th quarter worth approximately $80,000. Jennison Associates LLC boosted its position in shares of LifeStance Health Group by 278.4% during the fourth quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock valued at $59,597,000 after purchasing an additional 5,949,438 shares in the last quarter. Finally, Entropy Technologies LP bought a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $150,000. Institutional investors own 85.50% of the company's stock.

Insider Transactions at LifeStance Health Group

In related news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the transaction, the insider now directly owns 339,810 shares of the company's stock, valued at approximately $2,344,689. This represents a 5.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 3.20% of the company's stock.

Analyst Ratings Changes

LFST has been the topic of several research reports. William Blair restated an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. KeyCorp began coverage on LifeStance Health Group in a research note on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price target for the company. Canaccord Genuity Group began coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price objective for the company. Finally, UBS Group upgraded LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price objective for the company in a research report on Tuesday, May 27th. One analyst has rated the stock with a sell rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $8.50.

LifeStance Health Group Stock Performance

LFST traded down $0.03 during midday trading on Wednesday, reaching $5.93. The company had a trading volume of 500,238 shares, compared to its average volume of 1,591,184. The company has a market cap of $2.31 billion, a P/E ratio of -22.81 and a beta of 1.30. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The business has a 50-day moving average of $6.29 and a two-hundred day moving average of $7.11. LifeStance Health Group, Inc. has a 1 year low of $4.64 and a 1 year high of $8.61.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.